Showing results (701-710 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|December 13, 2012
Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPDRodger Kempsford, Virginia Norris, Sarah Siederer
Pulmonary Pharmacology & Therapeutics|January 3, 2013
Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammationBhawana Saluja, Jay N Thakkar, Hua Li, et al.
Pulmonary Pharmacology & Therapeutics|January 17, 2013
Epithelial regulation of eicosanoid production in asthmaTeal S Hallstrand, Ying Lai, William R Henderson, et al.
Pulmonary Pharmacology & Therapeutics|September 17, 2013
Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycinAnja Klemmer, Irene Krämer, Wolfgang Kamin
Pulmonary Pharmacology & Therapeutics|June 11, 2013
The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary diseaseC Compton, D McBryan, E Bucchioni, et al.
Pulmonary Pharmacology & Therapeutics|June 26, 2013
Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferationSun-Zhong Mao, Xiao-Fang Fan, Feng Xue, et al.
Pulmonary Pharmacology & Therapeutics|July 9, 2013
Chronic cough and pain: Janus faces in sensory neurobiology?Jessica O'Neill, Stephen B McMahon, Bradley J Undem
Pulmonary Pharmacology & Therapeutics|May 8, 2012
Smooth muscle in tissue remodeling and hyper-reactivity: airways and arteriesKristina Rydell-Törmänen, Paul-André Risse, Varsha Kanabar, et al.
Pulmonary Pharmacology & Therapeutics|December 17, 2013
The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functionsYukiko Saito, Masahide Takeda, Junko Nishikawa, et al.
Pulmonary Pharmacology & Therapeutics|November 26, 2013
Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathwayHe Li, Wei Lu, Wei-Wei Cai, et al.
Pageof 188